BusinessCannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City ApprovalsBy Nasdaq OMXMar 5, 2018, 2:23 PM UTC
BusinessCannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana Social Media Educational WebsiteBy Nasdaq OMXFeb 27, 2018, 12:42 PM UTC
BusinessCannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization OptionsBy Nasdaq OMXFeb 22, 2018, 12:39 PM UTC
BusinessCannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers JournalsBy Nasdaq OMXJan 18, 2018, 1:23 PM UTC
BusinessCannabis Science Actively Pursuing U.S. Federal Government Contracts and Is Preparing Applications for Submission While Confirming the CBIS Security Team (CBISST) is Ready for ActionBy Nasdaq OMXJan 9, 2018, 5:07 PM UTC
BusinessCBIS Reports on November 30, 2017 TRO Hearing and Next Steps; Hearing on a Preliminary Injunction Arguments Based on Information Disregarded by San Joaquin CountyBy Nasdaq OMXDec 4, 2017, 6:45 PM UTC
